Mike Zaman's  Instablog

Mike Zaman
Send Message
  • Merck & Co. Inc (MRK) The Insomniac's Wish, Perrigo Company PLC (PRGO) Impressive Performance 0 comments
    Aug 14, 2014 9:47 AM | about stocks: MRK, PRGO

    https://staticseekingalpha.a.ssl.fastly.net/uploads/2014/8/14/saupload_mrk.jpg Merck & Co. Inc. (NYSE:MRK)

    Sleep is increasingly recognized as important to public health, with sleep insufficiency linked to motor vehicle crashes, industrial disasters, and medical and other occupational errors.

    For many people trying to get to sleep or stay asleep can be a nightmare. Millions of Americans suffer from a sleep disorder called insomnia.

    According to guidelines from a physician group, insomnia is difficulty falling asleep or staying asleep, even when a person has the chance to do so. People with insomnia can feel dissatisfied with their sleep and usually experience one or more of the following: fatigue, low energy, difficulty concentrating, mood disturbances, and decreased performance in work or at school.

    Sometimes, insomnia only lasts a few days and goes away on its own, especially when the insomnia is tied to an obvious temporary cause, such as stress over an upcoming presentation, a painful breakup, or jet lag. Other times, insomnia is stubbornly persistent. Chronic insomnia is usually tied to an underlying mental or physical issue.

    MRK reported that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA(NYSE:R) (suvorexant) for adults with insomnia who have difficulty falling asleep and/or staying asleep.

    BELSOMRA is a highly selective antagonist for orexin receptors. Orexin is a neurotransmitter found in a specific part of the brain that can help keep a person awake. The mechanism by which BELSOMRA exerts its therapeutic effect is presumed to be through antagonism of orexin receptors.

    According to MRK, the FDA has recommended BELSOMRA be classified by the U.S. Drug Enforcement Administration (NYSE:DEA) as a scheduled product. Earlier this year, the DEA proposed a Schedule IV drug classification under the Controlled Substances Act. The DEA has not yet issued a final decision on the scheduling for BELSOMRA and therefore product cannot become available before that decision. BELSOMRA is expected to be available in late 2014 or early 2015


    MRK is a global healthcare leader working to help the world be well. MRK is known as MSD outside the United States and Canada.

    More about Merck & Co. Inc. (MRK) at www.merck.com


    https://staticseekingalpha.a.ssl.fastly.net/uploads/2014/8/14/saupload_prgo.jpg Perrigo Company PLC (NASDAQ:PRGO)

    Keep a close eye on PRGO. On its financial results, the company delivered year-over-year record sales and adjusted earnings for the ninth straight fiscal year.

    For the fourth quarter fiscal 2014, PRGO posted net sales of $1.14 billion, an 18% increase year over year, its adjusted net income increased 58% to $234 million or $1.74 per diluted share, and reported net income of $132 million, or $0.98 per diluted share.

    For the full fiscal 2014, PRGO's net sales were $4.06 billion, an increase of 15% over fiscal 2013, with organic growth of 7%.

    PRGO expects full-year fiscal 2015 adjusted earnings range of $7.20 to $7.50 per diluted share, an increase of 13% to 17% over fiscal 2014 adjusted earnings per share, and reported earnings of between $4.05 and $4.35 per diluted share.


    PRGO develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products and active pharmaceutical ingredients (NYSEMKT:API), and receives royalties from Multiple Sclerosis drug Tysabri(R). PRGO is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies.

    More about Perrigo Company PLC (PRGO) at www.perrigo.com


    Read Full Disclaimer at www.finance.crwe-pr.com/disclaimer

    Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

    Stocks: MRK, PRGO
Back To Mike Zaman's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.